Share

June 2015; 2 (3) ArticleOpen Access

The growing spectrum of antibody-associated inflammatory brain diseases in children

Sandra Bigi, Manisha Hladio, Marinka Twilt, Josep Dalmau, Susanne M. Benseler
First published April 2, 2015, DOI: https://doi.org/10.1212/NXI.0000000000000092
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
3052

Share

Article Information

vol. 2 no. 3 e92
DOI: 
https://doi.org/10.1212/NXI.0000000000000092
PubMed: 
25909091
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received October 15, 2014
  • Accepted in final form January 26, 2015
  • First Published April 2, 2015.
Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Sandra Bigi, MD, MSc*,
    2. Manisha Hladio, BSc, MSc*,
    3. Marinka Twilt, MD, MSc, PhD,
    4. Josep Dalmau, MD, PhD and
    5. Susanne M. Benseler, MD, MSc, PhD
  1. Sandra Bigi, MD, MSc*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) Swiss National Science Foundation (PBBSP3_144296) 2) Anna M?ller Grocholski Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Manisha Hladio, BSc, MSc*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Canadian Rheumatology Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Marinka Twilt, MD, MSc, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Josep Dalmau, MD, PhD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology, Neuroimmunology and Neuroinflammation Neurology UpToDate

    Patents:

    1. Patent for Ma2 autoantibody test, patent number: 6,387,639; Issued May 14th, 2002 Patent for NMDA receptor autoantibody test; US 7,972,796 B2 July 5, 2011; European 2057466 Patents filed for GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, and IgLON5 autoantibody test.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Advance Medical

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NMDAR autoantibody determination in the context of research.

    Research Support, Commercial Entities:

    1. Euroimmun, research support

    Research Support, Government Entities:

    1. NIH, RO1NS077851 (previously RO1CA107192), PI, 2011-2016 NIH, RO1CA89054, PI, 2008-2013 Fondo de Investigaciones Sanitarias de la Seguridad Social, ISCIII(Spanish Government), 14/00203, PI, 2012-2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NMDA receptor autoantibody test/Euroimmun GABA(B)R autoantibody test/Euroimmun GABA(A)R autoantibody test/Euroimmun DPPX autoantibody test/Euroimmun Iglon5 autoantibody test/Euroimmun

    Royalty Payments, Technology or Inventions:

    1. Patent Ma2 autoantibody test Patent NMDAR autoantibody test Patent application for the use of GABA(B) receptor, GABA (A) receptor, DPPX and IgLON5 autoantiboddy tests

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Susanne M. Benseler, MD, MSc, PhD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Pediatrics (S.B.), Division of Neurology; Department of Pediatrics (M.H.), Division of Rheumatology; and Department of Emergency Medicine and Research Institute (S.M.B.), The Hospital for Sick Children, University of Toronto, Ontario, Canada; Department of Pediatrics (S.B.), Division of Child Neurology, University Children's Hospital, Berne, Switzerland; Department of Pediatric Rheumatology (M.T.), Aarhus University Hospital, Aarhus, Denmark; Catalan Institution of Research and Advanced Studies (ICREA) and Biomedical Research Institute August Pi i Sunyer (IDIBAPS) (J.D.), Hospital Clinic, University of Barcelona, Spain; Department of Neurology (J.D.), University of Pennsylvania, Philadelphia; and Section of Rheumatology (S.M.B.), Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Alberta, Canada.
  1. Correspondence to Dr. Bigi: sandra.bigi{at}insel.ch
View Full Text

Article usage

Article usage: April 2015 to December 2022

AbstractFullPdfSource
Apr 201536824775Highwire
Apr 201506235pmc
May 20151624744Highwire
May 2015017797pmc
Jun 2015408395138Highwire
Jun 2015014384pmc
Jul 20159010150Highwire
Jul 201509267pmc
Aug 2015844235Highwire
Aug 201507856pmc
Sep 2015642017Highwire
Sep 201507854pmc
Oct 2015544415Highwire
Oct 201508446pmc
Nov 201548349Highwire
Nov 201509143pmc
Dec 201556238Highwire
Dec 201504828pmc
Jan 201657149Highwire
Jan 201607323pmc
Feb 2016415737Highwire
Feb 201605924pmc
Mar 2016532220Highwire
Mar 2016021320pmc
Apr 201658258Highwire
Apr 201606624pmc
May 2016433011Highwire
May 201604411pmc
Jun 201643205Highwire
Jun 201603918pmc
Jul 2016371710Highwire
Jul 201604319pmc
Aug 201654269Highwire
Aug 20160259pmc
Sep 201641207Highwire
Sep 201603211pmc
Oct 201624227Highwire
Oct 201605124pmc
Nov 201622248Highwire
Nov 201604312pmc
Dec 201623348Highwire
Dec 20160268pmc
Jan 201724221Highwire
Jan 20170397pmc
Feb 201727176Highwire
Feb 201703512pmc
Mar 201729161Highwire
Mar 201704015pmc
Apr 201715118Highwire
Apr 201783137pmc
May 201721167Highwire
May 2017143235pmc
Jun 20177182Highwire
Jun 201742929pmc
Jul 20171010628Highwire
Jul 2017125260pmc
Aug 2017161833Highwire
Aug 201773133pmc
Sep 201731511Highwire
Sep 2017102827pmc
Oct 201714127Highwire
Oct 201793760pmc
Nov 201717158Highwire
Nov 2017104261pmc
Dec 20172196Highwire
Jan 20181578Highwire
Feb 20180816Highwire
Mar 201801092Highwire
Apr 201814310Highwire
Apr 2018122730pmc
May 20182934Highwire
Jun 20180914Highwire
Jun 201841920pmc
Jul 201817510Highwire
Aug 20181815Highwire
Aug 201862729pmc
Sep 20183478Highwire
Oct 2018159711Highwire
Nov 20183995Highwire
Dec 20185578Highwire
Jan 20194467Highwire
Feb 20198387Highwire
Mar 201944014Highwire
Apr 20192527Highwire
May 20193438Highwire
Jun 201947210Highwire
Jul 201946012Highwire
Aug 20196337Highwire
Sep 201922013Highwire
Oct 201953810Highwire
Nov 201932513Highwire
Dec 20191297Highwire
Jan 202002814Highwire
Feb 20202326Highwire
Mar 202012711Highwire
Apr 202032814Highwire
May 20202467Highwire
Jun 202012710Highwire
Jul 20201221Highwire
Aug 20202184Highwire
Sep 20202509Highwire
Oct 20200537Highwire
Nov 202022314Highwire
Dec 202033617Highwire
Jan 202183518Highwire
Feb 20210263Highwire
Mar 202114316Highwire
Apr 202115514Highwire
May 202144917Highwire
Jun 202163510Highwire
Jul 202123318Highwire
Aug 202154314Highwire
Sep 202114017Highwire
Oct 202136829Highwire
Nov 202123420Highwire
Dec 202113410Highwire
Jan 202244118Highwire
Feb 202223019Highwire
Mar 20221428Highwire
Apr 20222298Highwire
May 202233914Highwire
Jun 20222335Highwire
Jul 20222263Highwire
Aug 202265412Highwire
Sep 202253418Highwire
Oct 202245311Highwire
Nov 202288115Highwire
Dec 20222279Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me